SARS-CoV-2 Dissemination Through Peripheral Nerves Explains Multiple Organ Injury
Open accessAbstract
Coronavirus disease (CoVID-19), caused by recently identified severe acute respiratory distress syndrome coronavirus 2 (SARS-CoV-2), is characterized by inconsistent clinical presentations. While many infected individuals remain asymptomatic or show mild respiratory symptoms, others develop severe pneumonia or even respiratory distress syndrome. SARS-CoV-2 is reported to be able to infect the lungs, the intestines, blood vessels, the bile ducts, the conjunctiva, macrophages, T lymphocytes, the heart, liver, kidneys, and brain. More than a third of cases displayed neurological involvement, and many severely ill patients developed multiple organ infection and injury. However, less than 1% of patients had a detectable level of SARS-CoV-2 in the blood, raising a question of how the virus spreads throughout the body. We propose that nerve terminals in the orofacial mucosa, eyes, and olfactory neuroepithelium act as entry points for the brain invasion, allowing SARS-CoV-2 to infect the brainstem. By exploiting the subcellular membrane compartments of infected cells, a feature common to all coronaviruses, SARS-CoV-2 is capable to disseminate from the brain to periphery via vesicular axonal transport and passive diffusion through axonal endoplasmic reticula, causing multiple organ injury independently of an underlying respiratory infection. The proposed model clarifies a wide range of clinically observed phenomena in CoVID-19 patients, such as neurological symptoms unassociated with lung pathology, protracted presence of the virus in samples obtained from recovered patients, exaggerated immune response, and multiple organ failure in severe cases with variable course and dynamics of the disease. We believe that this model can provide novel insights into CoVID-19 and its long-term sequelae, and establish a framework for further research.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Because SARS-CoV-2 can spread directly between cells without entering extracellular space, antibodies that only recognize intact extracellular virions may poorly limit within-host spread.
“SARS-CoV-2 is able to spread from cell to cell without exposure to the extracellular environment38, and it is therefore possible that antibodies that only target intact extracellular viral particles have a limited role in reducing viral spread within the host.”
From Immunological mechanisms of vaccine-induced protection against COVID-19 in humans (2021) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
The citation lists haven’t been fetched yet
References 168 · Cited by 95
Research works printed but not linked: 7
- Canetta C. Accordino S. Buscarini E. Benelli G. La Piana G. Scartabellati A. (2020). Syncope at SARS-CoV-2 onset due to impaired baroreflex response. medRxiv [Preprint] 10.1101/2020.05.29.20114751 PMC7505046 32977101 · DOI
- Chen X. Zhao B. Qu Y. Chen Y. Xiong J. Feng Y. (2020b). Detectable serum SARS-CoV-2 viral load (RNAaemia) is closely associated with drastically elevated interleukin 6 (IL-6) level in critically ill COVID-19 patients. Clin. Infect. Dis. 17: ciaa449. 10.1093/cid/ciaa449 [Epub ahead of print]. 32301997 PMC7184354 · DOI
- Hui K. Cheung M.-C. Perera R. A. P. M. Ng K.-C. Bui C. Ho J. (2020). Tropism of the novel coronavirus SARS-CoV-2 in human respiratory tract: an analysis in ex vivo and in vitro cultures. SSRN Electron. J. 1: e10. PMC7252187 32386571
- Jaimes J. A. André N. M. Millet J. K. Whittaker G. R. (2020). Structural modeling of 2019-novel coronavirus (nCoV) spike protein reveals a proteolytically-sensitive activation loop as a distinguishing feature compared to SARS-CoV and related SARS-like coronaviruses. bioRxiv [Preprint] 10.1101/2020.02.10.942185 32511311 PMC7217298 · DOI
- Khan G. Ahmed W. Rony P. (2017). Exosomes and their role in viral infections. Open Virol. J. 12 134– 148. PMC6187740 30416610
- Pinto B. G. Oliveira A. E. Singh Y. Jimenez L. Goncalves A. N. Ogava R. L. (2020). ACE2 expression is increased in the lungs of patients with comorbidities associated with severe COVID-19. medRxiv [Preprint]. 10.1101/2020.03.21.20040261. 32526012 PMC7377288 · DOI
- Yue W. L. (2007). Nasal mucociliary clearance in patients with diabetes mellitus. J. Laryngol. Otol. 103 853– 855. 10.1017/s0022215100110291 2584876 · DOI
- Authors
- Fenrich, M., Mrdenovic, S., Balog, M., Tomic, S., Zjalic, M., Roncevic, A., Mandic, D., Debeljak, Z., & Heffer, M.
- Affiliations
- University of Osijek (HR)
- Corresponding author
- Fenrich, Matija
- Heffer, Marija
- Venue
- Frontiers in Cellular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2020-08-05
- Volume
- 14
- Pages
- 229-229
- ISSN
- 1662-5102 (ISSN-L)
- PMC
- PMC7419602
- OpenAlex
- W3039136126
- Cited by
- 95
- References
- 168
- Citations by year
- 2026: 5 · 2025: 6 · 2024: 10 · 2023: 9 · 2022: 22 · 2021: 37 · 2020: 6
- FWCI
- 8.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Frontiers in Cellular Neuroscience (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- European Regional Development Fund (KK.01.1.1.01.0007)
- Hrvatska Zaklada za Znanost (HRZZ IP-2014-09-2324)
- Topics
- Health Sciences › Medicine › Neurology › Long-Term Effects of COVID-19
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › COVID-19 Clinical Research Studies
- Keywords
- SARS-CoV-2, COVID-19 pandemic, multiple organ injury, olfactory epithelium, axonal transport, endoplasmic reticulum, brainstem infection, neurological symptoms, viral persistence, multiple organ failure, long COVID
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review